Cargando…
Gut Dysbiosis in Pancreatic Diseases: A Causative Factor and a Novel Therapeutic Target
Pancreatic-related disorders such as pancreatitis, pancreatic cancer, and type 1 diabetes mellitus (T1DM) impose a substantial challenge to human health and wellbeing. Even though our understanding of the initiation and progression of pancreatic diseases has broadened over time, no effective therape...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885515/ https://www.ncbi.nlm.nih.gov/pubmed/35242797 http://dx.doi.org/10.3389/fnut.2022.814269 |
_version_ | 1784660439667310592 |
---|---|
author | Zhang, Tao Gao, Guangqi Sakandar, Hafiz Arbab Kwok, Lai-Yu Sun, Zhihong |
author_facet | Zhang, Tao Gao, Guangqi Sakandar, Hafiz Arbab Kwok, Lai-Yu Sun, Zhihong |
author_sort | Zhang, Tao |
collection | PubMed |
description | Pancreatic-related disorders such as pancreatitis, pancreatic cancer, and type 1 diabetes mellitus (T1DM) impose a substantial challenge to human health and wellbeing. Even though our understanding of the initiation and progression of pancreatic diseases has broadened over time, no effective therapeutics is yet available for these disorders. Mounting evidence suggests that gut dysbiosis is closely related to human health and disease, and pancreatic diseases are no exception. Now much effort is under way to explore the correlation and eventually potential causation between the gut microbiome and the course of pancreatic diseases, as well as to develop novel preventive and/or therapeutic strategies of targeted microbiome modulation by probiotics, prebiotics, synbiotics, postbiotics, and fecal microbiota transplantation (FMT) for these multifactorial disorders. Attempts to dissect the intestinal microbial landscape and its metabolic profile might enable deep insight into a holistic picture of these complex conditions. This article aims to review the subtle yet intimate nexus loop between the gut microbiome and pancreatic diseases, with a particular focus on current evidence supporting the feasibility of preventing and controlling pancreatic diseases via microbiome-based therapeutics and therapies. |
format | Online Article Text |
id | pubmed-8885515 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88855152022-03-02 Gut Dysbiosis in Pancreatic Diseases: A Causative Factor and a Novel Therapeutic Target Zhang, Tao Gao, Guangqi Sakandar, Hafiz Arbab Kwok, Lai-Yu Sun, Zhihong Front Nutr Nutrition Pancreatic-related disorders such as pancreatitis, pancreatic cancer, and type 1 diabetes mellitus (T1DM) impose a substantial challenge to human health and wellbeing. Even though our understanding of the initiation and progression of pancreatic diseases has broadened over time, no effective therapeutics is yet available for these disorders. Mounting evidence suggests that gut dysbiosis is closely related to human health and disease, and pancreatic diseases are no exception. Now much effort is under way to explore the correlation and eventually potential causation between the gut microbiome and the course of pancreatic diseases, as well as to develop novel preventive and/or therapeutic strategies of targeted microbiome modulation by probiotics, prebiotics, synbiotics, postbiotics, and fecal microbiota transplantation (FMT) for these multifactorial disorders. Attempts to dissect the intestinal microbial landscape and its metabolic profile might enable deep insight into a holistic picture of these complex conditions. This article aims to review the subtle yet intimate nexus loop between the gut microbiome and pancreatic diseases, with a particular focus on current evidence supporting the feasibility of preventing and controlling pancreatic diseases via microbiome-based therapeutics and therapies. Frontiers Media S.A. 2022-02-15 /pmc/articles/PMC8885515/ /pubmed/35242797 http://dx.doi.org/10.3389/fnut.2022.814269 Text en Copyright © 2022 Zhang, Gao, Sakandar, Kwok and Sun. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Nutrition Zhang, Tao Gao, Guangqi Sakandar, Hafiz Arbab Kwok, Lai-Yu Sun, Zhihong Gut Dysbiosis in Pancreatic Diseases: A Causative Factor and a Novel Therapeutic Target |
title | Gut Dysbiosis in Pancreatic Diseases: A Causative Factor and a Novel Therapeutic Target |
title_full | Gut Dysbiosis in Pancreatic Diseases: A Causative Factor and a Novel Therapeutic Target |
title_fullStr | Gut Dysbiosis in Pancreatic Diseases: A Causative Factor and a Novel Therapeutic Target |
title_full_unstemmed | Gut Dysbiosis in Pancreatic Diseases: A Causative Factor and a Novel Therapeutic Target |
title_short | Gut Dysbiosis in Pancreatic Diseases: A Causative Factor and a Novel Therapeutic Target |
title_sort | gut dysbiosis in pancreatic diseases: a causative factor and a novel therapeutic target |
topic | Nutrition |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885515/ https://www.ncbi.nlm.nih.gov/pubmed/35242797 http://dx.doi.org/10.3389/fnut.2022.814269 |
work_keys_str_mv | AT zhangtao gutdysbiosisinpancreaticdiseasesacausativefactorandanoveltherapeutictarget AT gaoguangqi gutdysbiosisinpancreaticdiseasesacausativefactorandanoveltherapeutictarget AT sakandarhafizarbab gutdysbiosisinpancreaticdiseasesacausativefactorandanoveltherapeutictarget AT kwoklaiyu gutdysbiosisinpancreaticdiseasesacausativefactorandanoveltherapeutictarget AT sunzhihong gutdysbiosisinpancreaticdiseasesacausativefactorandanoveltherapeutictarget |